Delivery Order SPE2DB22D1106-SPE2DB25FEKU4

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $2,475.20 and a period of performance through April 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $1,017.23 and a performance period through December 26, 2024. The contract is not designated as a set-aside. In addition to this delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Erythromycin 0.5% eye ointment with a potential value of $1,281.36 and a performance period through March 6, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $2,324.16 and a period of performance through January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Erythromycin 0.5% eye ointment, a prescription medication, with a ceiling value of $1,402.59 and an ultimate completion date of January 6, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide 4,563,764,320 units of Erythromycin 0.5% eye ointment in 3.5 gram tubes. The contract has a ceiling value of $1,227.68 and a period of performance through February 27, 2024. AmerisourceBergen Drug Corp is the prime contractor and has not been awarded the contract under any set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Erythromycin 0.5% eye ointment, 3.5 grams, with a firm fixed price of $2,330.41 and a completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $2,445.67 and a completion date of June 21, 2024. The contract is a Firm Fixed Price (FFP) Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,865.14, is for the delivery of 4567983110 - Erythromycin 0.5% Eye Ointment 3.5GM. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Erythromycin 0.5% Eye Ointment 3.5gm, with a potential value of $1,520.00 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation noted. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEKU4
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Erythromycin 0.5% eye ointment, with a ceiling value of $2,072.22 and a period of performance through April 29, 2025. The contract is not set aside for any specific business category.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/28/25, 11:02 AM